These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1553776)

  • 1. [Prolastin in the treatment of mild emphysema in patients with alpha 1-protease inhibitor deficiency].
    Ulrik CS; Dirksen A; Kok-Jensen A
    Ugeskr Laeger; 1992 Mar; 154(12):811-2. PubMed ID: 1553776
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha 1-proteinase inhibitor for alpha 1-antitrypsin deficiency.
    Med Lett Drugs Ther; 1988 Mar; 30(761):29-30. PubMed ID: 3257810
    [No Abstract]   [Full Text] [Related]  

  • 3. Alpha 1-antitrypsin augmentation therapy.
    Sandhaus RA
    Agents Actions Suppl; 1993; 42():97-102. PubMed ID: 8356934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.
    Louie SG; Sclar DA; Gill MA
    Ann Pharmacother; 2005 Nov; 39(11):1861-9. PubMed ID: 16219903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Possibilities of the prevention and treatment of pulmonary emphysema in the light of the "proteolytic" theory of its pathogenesis].
    Nowak D
    Pneumonol Pol; 1985 Oct; 53(10):492-6. PubMed ID: 3912732
    [No Abstract]   [Full Text] [Related]  

  • 6. [Role of certain mechanisms in the pathogenesis of emphysema and a number of other lung diseases].
    Putov NV; Pokhodzeĭ IV; Kolodkina LA
    Ter Arkh; 1985; 57(3):144-8. PubMed ID: 3890255
    [No Abstract]   [Full Text] [Related]  

  • 7. Alpha-1-antitrypsin replacement therapy: current status.
    Abusriwil H; Stockley RA
    Curr Opin Pulm Med; 2006 Mar; 12(2):125-31. PubMed ID: 16456382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities for the development of specific therapeutic agents to treat emphysema.
    Cohen AB
    Am Rev Respir Dis; 1979 Oct; 120(4):723-7. PubMed ID: 389114
    [No Abstract]   [Full Text] [Related]  

  • 9. Augmentation therapy in alpha-1 antitrypsin deficiency.
    Heresi GA; Stoller JK
    Expert Opin Biol Ther; 2008 Apr; 8(4):515-26. PubMed ID: 18352854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Elastase, elastase inhibitors and chronic obstructive lung diseases].
    Kramps JA; Dijkman JH
    Ned Tijdschr Geneeskd; 1990 Jun; 134(23):1127-30. PubMed ID: 2192289
    [No Abstract]   [Full Text] [Related]  

  • 11. Comment: comparisons of Aralast and Prolastin, alpha1-protease inhibitors for treatment of alpha1-antitrypsin deficiency.
    Petteway SR
    Ann Pharmacother; 2006 Feb; 40(2):353-4; author reply 354. PubMed ID: 16449545
    [No Abstract]   [Full Text] [Related]  

  • 12. Alpha 1-PI for emphysema due to alpha 1-antitrypsin deficiency.
    Horowitz ID; Schulman ES
    Am Fam Physician; 1989 Sep; 40(3):223-8. PubMed ID: 2672752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Difficulties in controlled inhalation of alpha 1-protease inhibitor].
    Brand P; Maas Enriquez M; Meyer T; Scheuch G; Weber N
    Pneumologie; 2003 Mar; 57(3):153-8. PubMed ID: 12632295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Replacement therapy of emphysema caused by alpha 1-antitrypsin deficiency].
    Vidal R; Miravitlles M; de Gracia X; Gallego B; Morell F
    Med Clin (Barc); 1991 Feb; 96(5):180-2. PubMed ID: 2033989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
    Franciosi AN; McCarthy C; McElvaney NG
    Expert Rev Respir Med; 2015 Apr; 9(2):143-51. PubMed ID: 25598013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cigarette smoking and the etiopathogenesis of pulmonary emphysema].
    Górecka D
    Pneumonol Pol; 1984 Jul; 52(7):353-7. PubMed ID: 6387638
    [No Abstract]   [Full Text] [Related]  

  • 17. [Practical applications of recombinant alpha-1-antitrypsin in medicine].
    Kabziński J; Kedziora J; Majsterek I
    Pol Merkur Lekarski; 2010 Dec; 29(174):345-50. PubMed ID: 21298982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The evolution of the replacement treatment of emphysema due to alpha 1-antitrypsin deficiency].
    Manresa F
    Arch Bronconeumol; 1995; 31(7):371-2. PubMed ID: 8777536
    [No Abstract]   [Full Text] [Related]  

  • 19. Commercial plasma alpha1-antitrypsin (Prolastin) contains a conformationally inactive, latent component.
    Lomas DA; Elliott PR; Carrell RW
    Eur Respir J; 1997 Mar; 10(3):672-5. PubMed ID: 9073003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alpha 1-antitrypsin deficiency and emphysema. Replacement therapy?].
    Johansen S; Gulsvik A
    Tidsskr Nor Laegeforen; 1989 Aug; 109(22):2142-5. PubMed ID: 2788939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.